Discusses considerations for medical devices intended to benefit patients suffering from rare diseases or conditions in the European Union. Call for amendments to regulations to provide incentives to medical device manufacturers; Goal of increasing research and development into solutions for rare diseases....
Track 06:Advancing Research for rare diseases Rare disease researchis difficult due to the scarcity of patient information on the conditions. Because there are so few people affected, patient recruitment for clinical studies might be very difficult. To address these difficulties, a number of charities...
A device alarming small and big seizures in rare epilepsy conditions. Similar to orphan drugs, there is much research and development needed in this area, incentives to stimulate authorization and reimbursement, tools for patient involvement and materiovigilance. ...
Rare diseases, affecting fewer than 1 in 2,000 individuals, pose unique challenges due to limited research and treatment options. Orphan drugs, developed to treat these conditions, require special incentives for pharmaceutical companies due to low market demand. This is crucial for patients who often...
- 《Higher Education Research & Development》 被引量: 47发表: 2006年 Coverage and Reimbursement: Incentives and Disincentives for Product Development - Rare Diseases and Orphan Products - NCBI Bookshelf A small market is generally viewed as a disincentive for the development of drugs. Many of the...
One of the challenges of diagnosing diseases is identifying them early. At this stage, signs may be vague or confusing, or difficult to identify. Early diagnosis is often tied to the best possible treatment outcomes, so there’s plenty of incentives to improve methods in this way. ...
An auto-ethnographic study of co-produced health research in a patient organisation: unpacking the good, the bad, and the unspoken In rare diseases, limited access to services and rare disease experts may force families to act as medical advocates for their child; they can volunteer to... A...
Visit our Resource Center to view free webcasts and charts or read publications, news, and research reports on the Asia medical markets. Home Business Development Services Regulatory Services Target Asian Markets Resource Center Why Choose Us Medical Device & IVD Business Development Services Regulatory...
Although the goal of translational research is to bring biomedical knowledge from the laboratory to clinical trial and therapeutic products for improving health, this goal has not been well achieved as often as desired because of many barriers documented
Solely data-driven approaches to covariate selection can negatively affect the precision of the estimates and even amplify the residual bias52,53, and are a particular concern in EHR research, where informative missingness is the rule41,42. When adjusting for sources of confounding, both VanderWeele...